Not Tagged
Not Tagged
['melanoma']
interested in the the #aacr23 major symposium on the future of phase i clinical trials? check out this review article "tissue agnostic activity of braf plus mek inhibitor in braf v600 mutant tumorsbraf in nonmelanoma cancers" by 
The go-to journal for transitioning experimental therapies developed at the bench into clinical investigation, from preclinical study to Phase I trials.